Corporate Assignee
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
Corporate Assignee
active
No affiliations
Method of treatment of hormone-unresponsive metastiatic prostate
Post-translational activation of TGF-.beta..sub.1 involving the
LandOfFree
Manitoba Cancer Treatment and Research Foundation does not yet have a rating. At this time, there are no reviews or comments for this inventor.
If you have personal experience with Manitoba Cancer Treatment and Research Foundation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Manitoba Cancer Treatment and Research Foundation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-P-1472415